N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection

Xianfeng Hui, Shuoxiang Gao, Shihuan Ding, Mengyi Li, Xiaowei Tian

Open source

DOI
10.3389/fimmu.2026.1878455
Published
2026-09-02
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1878455,
  title = {N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection},
  author = {Xianfeng Hui and Shuoxiang Gao and Shihuan Ding and Mengyi Li and Xiaowei Tian},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1878455},
  url = {https://doi.org/10.3389/fimmu.2026.1878455}
}

RIS

TY  - JOUR
TI  - N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection
AU  - Xianfeng Hui
AU  - Shuoxiang Gao
AU  - Shihuan Ding
AU  - Mengyi Li
AU  - Xiaowei Tian
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1878455
UR  - https://doi.org/10.3389/fimmu.2026.1878455
ER  - 

APA

Hui, X., Gao, S., Ding, S., Li, M., & Tian, X. (2026). N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1878455

Source records